When was Chiasma, Inc. stock made available for the first time to the public?

The IPO Date for Chiasma, Inc. is 2015-07-16. On this 2015-07-16, Chiasma, Inc. stock was made publicly available.

Where is the headquarters of Chiasma, Inc. stock?

Headquarters of Chiasma, Inc. is in US at 140 Kendrick Street, Building C East, Needham, MA 02451.

What industry does Chiasma, Inc. belong to?

The Chiasma, Inc. belongs to Biotechnology.

Chiasma, Inc.

CHMA•NASDAQ

Healthcare

Biotechnology

$3.76

$-0.24(-6.00%)

Chiasma, Inc. (CHMA) Company Profile & Overview

Explore Chiasma, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Chiasma, Inc. (CHMA) Company Profile & Overview

Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.

SectorHealthcare

IndustryBiotechnology

CEORaj Kannan

Contact Information

http://www.chiasma.com

16179285300

140 Kendrick Street, Building C East, Needham, MA, 02451

Company Facts

84 Employees

IPO DateJul 16, 2015

CountryUS

Frequently Asked Questions

;